IMG Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
IMG Wealth Management's VRTX Position: Q2 2026 in Review
IMG Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 22% in Q2 2026, buying an estimated $3.54K and bringing the position to 45 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #241.
IMG Wealth Management first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.8K in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- IMG Wealth Management held 45 shares of Vertex Pharmaceuticals worth $22.4K as of Q2 2026.
- IMG Wealth Management bought 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
- Vertex Pharmaceuticals made up 0.01% of IMG Wealth Management's portfolio in Q2 2026, its #241 holding.
- IMG Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- IMG Wealth Management's Vertex Pharmaceuticals position peaked at $30.8K in Q4 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.